Precision BioLogic today unveiled data from a study using a new kit for a Modified Nijmegen-Bethesda Assay (MNBA) at the International Society on Thrombosis and Haemostasis’ Scientific and Standardization Committee (SSC) meeting in Dublin.
News & Events
May 18, 2018
Precision BioLogic will present data at the World Federation of Hemophilia (WFH) 2018 World Congress in Glasgow, Scotland, May 20-24. Recognizing the need to improve Factor VIII (FVIII) inhibitor testing for people with hemophilia A, the company studied the agreement between a chromogenic Modified Nijmegen-Bethesda Assay (MNBA) and a qualitative ELISA test in the detection of FVIII inhibitors in plasma samples.
Here’s a list of conferences we’ll be attending this year. If you’re planning on attending any of the same shows, be sure to swing by our booth for a chat because, after all, it’s you we want to see.
08 to 10
San Diego, CA - Visit us at Booth 115
20 to 24
Glasgow, Scotland - Visit us at Booth 17
18 to 21
Dublin, Ireland - Visit us at Booth G1
31 to 02
01 to 03